JAMA Network Home
Sign In
Research Letter

Isotretinoin Risk Evaluation and Mitigation Strategy and Pregnancy Incidence

JAMA Internal Medicine 10.1001/jamainternmed.2025.3168

July 21, 2025 at 11:00 AM EDT

Read the full article

This cohort study examines pregnancy incidence among publicly and commercially insured female patients using isotretinoin vs topical retinoids, stratified by patient characteristics.

Corresponding Author: Yanmin Zhu, PhD, MS, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, 1620 Tremont St, Ste 3030, Boston 02120 (yzhu15@bwh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.3168?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072125

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks